Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin versus vancomycin for prevention of infection in spinal fusion surgery
IRCT20250508065643N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2025
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Cefazolin prophylaxis with Vancomycin prophylaxis (2 arms). Primary endpoint: Postoperative infection incidence. Started May 2025; status: completed.
02
Drugs
cefazolinvancomycin
Beyond the preview
Go deeper on IRCT20250508065643N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250508065643N1.